Skip to main content
. Author manuscript; available in PMC: 2013 Nov 6.
Published in final edited form as: Cancer Biomark. 2012;11(0):10.3233/CBM-2012-0265. doi: 10.3233/CBM-2012-0265

Fig. 1.

Fig. 1

Determination of median and 95% confidence interval of the predicted probability of recurrence of each ovarian cancer patient. This measurement was based on the performance of antigen biomarkers namely, Mec1 4B7 (A), Mec1 5H6 (B) individually, in combination (C), using logistic regression bootstrapped algorithm, and Mec1 4H4 (D) using CART bootstrapped algorithm. (Colours are visible in the online version of the article; http://dx.doi.org/10.3233/CBM-2012-0265)